Biotech & Life Sciences Global Venture Congress 2006 (GVC 2006)

Venue: Madison Square Garden

Location: New York, New York, United States

Event Date/Time: Sep 14, 2006 End Date/Time: Sep 15, 2006
Registration Date: Sep 05, 2006
Early Registration Date: Aug 01, 2006
Report as Spam


The Biotech & Life Sciences Global Venture Congress™ conference is a two-day conference designed to explore the frontiers of biotech & life sciences, address the venture capital landscape, identify current trends in innovation, learn scientific discoveries and discover cutting-edge Biotech and Life Sciences companies. As a delegate-driven conference, it targets visionaries, researchers, investors, and entrepreneurs who want to do extraordinary things.

Throughout the conference, 30+ actively investing top-tier Biotech & Life Science Venture Capitalists will address various issues during seven panel discussions.

Exhibitor & Presentation Opportunities: There are limited opportunities available to companies seeking funding to exhibit or present. Applications will be considered on a first-come, first-served basis. See website for detail.

Representative Speakers: (see website for updates and more)

John Maroney, General Partner, Delphi Ventures; Stewart J. Hen, Managing Director, Warburg Pincus; Markus Goebel, Ph.D., M.D., Managing Director, Novartis Venture Fund; Caley M. Castelein, M.D., Managing Partner, Thomas Weisel Healthcare Venture Partners; Philip L. Smith, Ph.D., General Partner, SR One; Jim Sherblom, Managing General Partner, Seaflower Ventures; J. Gordon Foulkes, Ph.D., Venture Partner, RiverVest Venture Partners; Arthur Klausner, Partner, Pappas Ventures; Gyan Parida, Ph.D., President/CEO, SAEC, SAEC Ventures; Jonathan T. Silverstein, General Partner, OrbiMed Advisors; Dan Burstein, Managing Partner, Millennium Technology Ventures; Andrew D. Firlik, M.D., General Partner, Foundation Medical Partners; Timothy F. Howe, Partner, CHL Medical Partners; Rodney D. Altman, M.D., Senior Partner, CMEA Ventures; David F. Hendren, Managing Director/Founder, Catalyst Health & Technology Partners; John Wilkerson, Ph.D., Managing Director/Co-founder, Galen Partners; Paul M. Kelley, Chairman/Founder, Zero Stage Capital; Alfred Scheidegger, Ph.D., Founding Partner & CEO, Nextech Venture Ltd.(Zurich); Scott Minick, Managing Director, ARCH Venture Partners; Jerry Benjamin, General Partner Advent Venture Partners… and more